Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2127 (LINC02127)

Target
LINC02127
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2127 (LINC02127) is a member of the long intergenic non-coding RNA (lincRNA) family, defined as an autonomously transcribed RNA longer than 200 nucleotides that does not overlap with any protein-coding region[1][5][7]. LINC02127, like other lincRNAs, is presumed to participate in the regulation of neighboring or distant gene expression, potentially through mechanisms such as chromatin remodeling, transcriptional regulation, or RNA stabilization[1][3][5]. While some lincRNAs have well-characterized biological roles and relevance in disease (such as XIST and HOTAIR), the specific biological, disease-associated, or therapeutic target properties of LINC02127 have not been established in the medical or research literature to date[3][1]. There are no known drug interactions, biomarker uses, or disease roles specifically attributed to LINC02127. It is not considered a therapeutic target such as a receptor, enzyme, or transporter, but rather a non-coding RNA with potential roles in gene regulation typical of the lincRNA family[1][5][7].\n\nNote: The absence of LINC02127 from disease or target databases and its classification as a non-coding RNA indicate it is not a canonical drug target or established disease biomarker, nor are there known safety-related concerns. No evidence of misspelling or identity confusion is present based on current genomic databases[7][1][5].

Other names
LINC02127
02

Biological functions

Regulation of gene expressionPossible chromatin remodelingTranscriptional regulationRNA stabilization

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2127 (LINC02127).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2127 (LINC02127).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call